Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,300
Closed -$215K 7698
2020
Q1
$215K Hold
3,300
﹤0.01% 4667
2019
Q4
$260K Hold
3,300
﹤0.01% 4961
2019
Q3
$263K Buy
+3,300
New +$259K ﹤0.01% 4916
2018
Q2
Sell
-90,000
Closed -$6.92M 7758
2018
Q1
$6.92M Buy
+90,000
New +$6.65M 0.01% 1505
2017
Q1
Sell
-7,000
Closed -$347K 7361
2016
Q4
$347K Hold
7,000
﹤0.01% 4767
2016
Q3
$367K Buy
+7,000
New +$343K ﹤0.01% 4174
2015
Q1
Sell
-99,000
Closed -$3.77M 7468
2014
Q4
$3.77M Hold
99,000
﹤0.01% 1998
2014
Q3
$3.51M Buy
+99,000
New +$3.68M ﹤0.01% 2123

Other funds holding XYL

Citigroup's XYL Position: Q1 2026 in Review

Citigroup increased its Xylem (XYL) stake by 58% in Q1 2026, buying an estimated $12.9M and bringing the position to 267,869 shares worth $32M. The position accounts for 0.01% of the portfolio, ranked #839.

Citigroup first reported a position in XYL in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.7M in Q4 2020. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Citigroup held 267,869 shares of Xylem worth $32M as of Q1 2026.
  • Citigroup bought 98,174 Xylem shares in Q1 2026, an estimated $12.9M.
  • Xylem made up 0.01% of Citigroup's portfolio in Q1 2026, its #839 holding.
  • Citigroup first reported a position in Xylem in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Xylem position peaked at $51.7M in Q4 2020.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.